Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-081510
Filing Date
2015-11-20
Accepted
2015-11-20 16:06:38
Documents
2
Period of Report
2015-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10933
2 POA DOCUMENT poa.txt EX-24.4_616034 3469
  Complete submission text file 0001209191-15-081510.txt   15756
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
ALTSHULER DAVID (Reporting) CIK: 0001550395 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 151246755